2.96
price up icon3.50%   0.10
after-market Dopo l'orario di chiusura: 2.73 -0.23 -7.77%
loading
Precedente Chiudi:
$2.86
Aprire:
$3.19
Volume 24 ore:
481.36K
Relative Volume:
0.53
Capitalizzazione di mercato:
$4.35M
Reddito:
$502.40K
Utile/perdita netta:
$-7.91M
Rapporto P/E:
-0.2968
EPS:
-9.972
Flusso di cassa netto:
$-4.32M
1 W Prestazione:
+11.28%
1M Prestazione:
+24.89%
6M Prestazione:
-50.25%
1 anno Prestazione:
-82.74%
Intervallo 1D:
Value
$2.70
$3.24
Intervallo di 1 settimana:
Value
$2.5475
$3.67
Portata 52W:
Value
$1.41
$35.99

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Nome
60 Degrees Pharmaceuticals Inc
Name
Telefono
202-327-5422
Name
Indirizzo
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Dipendente
3
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SXTP's Discussions on Twitter

Confronta SXTP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
2.96 3.92M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

60 Degrees Pharmaceuticals Inc Borsa (SXTP) Ultime notizie

pulisher
11:01 AM

60 Degrees Pharmaceuticals Inc (SXTP) Has A Gold Mine On Its Hands - Stocksregister

11:01 AM
pulisher
08:37 AM

60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - mx.advfn.com

08:37 AM
pulisher
08:37 AM

SXTP60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - mx.advfn.com

08:37 AM
pulisher
08:34 AM

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health - mx.advfn.com

08:34 AM
pulisher
Jun 04, 2025

60 Degrees Pharmaceuticals introduces new malaria drug packaging By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format - GlobeNewswire Inc.

Jun 04, 2025
pulisher
Jun 04, 2025

60 Degrees announces results from an insurance claims analysis on babesiosis - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesi - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

60 Degrees Pharmaceuticals (SXTP) Reveals New Insights on Babesiosis and Chronic Fatigue | SXTP Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Gulf Keystone Petroleum (OTCMKTS:GUKYF) Trading 5.9% Higher – Should You Buy? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

PROG Holdings, Inc. (NYSE:PRG) Short Interest Update - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Mobileye Global Inc. (NASDAQ:MBLY) Given Consensus Rating of “Hold” by Analysts - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Polar Power, Inc. (NASDAQ:POLA) Sees Significant Decline in Short Interest - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Woodside Energy Group Ltd (NYSE:WDS) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Goldmoney (OTCMKTS:XAUMF) Shares Up 0.6% – Still a Buy? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

FTI Foodtech International (CVE:FTI) Stock Price Up 2.3% – Still a Buy? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Stelco (OTCMKTS:STZHF) Shares Up 1.1% – What’s Next? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Trevi Therapeutics (NASDAQ:TRVI) Given “Buy” Rating at D. Boral Capital - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

iShares ESG Aware MSCI EM ETF (NASDAQ:ESGE) Short Interest Update - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Southwest Gas Holdings, Inc. (NYSE:SWX) Sees Large Increase in Short Interest - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Muscle Maker (NASDAQ:GRIL) Trading Down 4.2% – What’s Next? - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Price Target Raised to $7.00 at Ascendiant Capital Markets - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

CIIG Merger (OTCMKTS:CIICU) Trading Down 5.1% – Here’s What Happened - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Kidoz (CVE:KIDZ) Trading 2.9% Higher – Should You Buy? - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Ascendiant Capital lowers 60 Degrees stock price target to $7 By Investing.com - Investing.com India

Jun 02, 2025
pulisher
Jun 02, 2025

Ascendiant Capital Raises Price Target for SXTP to $7.00 | SXTP Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Ascendiant Capital lowers 60 Degrees stock price target to $7 - Investing.com

Jun 02, 2025
pulisher
May 31, 2025

Ulta Beauty (NASDAQ:ULTA) Shares Gap Up Following Better-Than-Expected Earnings - Defense World

May 31, 2025
pulisher
May 31, 2025

Uber Technologies, Inc. (NYSE:UBER) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 31, 2025
pulisher
May 27, 2025

4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World

May 27, 2025
pulisher
May 27, 2025

Research Analysts’ Recent Ratings Changes for Adaptimmune Therapeutics (ADAP) - Defense World

May 27, 2025
pulisher
May 27, 2025

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Given Sell (E+) Rating at Weiss Ratings - Defense World

May 27, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Acquires New Position in FARO Technologies, Inc. (NASDAQ:FARO) - Defense World

May 26, 2025
pulisher
May 25, 2025

Live Radar: Track thunderstorms as they move across Southeast Georgia and Northeast Florida (Video) - Spot On Florida

May 25, 2025
pulisher
May 25, 2025

Cetera Investment Advisers Has $876,000 Stock Holdings in Goldman Sachs BDC, Inc. (NYSE:GSBD) - Defense World

May 25, 2025
pulisher
May 19, 2025

Pre-market Movers: CMRX, CPIX, PBM, CRVO... - RTTNews

May 19, 2025
pulisher
May 16, 2025

VSee Health Launches AI-Powered Telehealth to Reduce Maternal Deaths in Remote Philippines - Quantisnow

May 16, 2025
pulisher
May 15, 2025

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation - The Manila Times

May 15, 2025
pulisher
May 15, 2025

60 Degrees Pharmaceuticals, Inc. Reports 55% Increase in Q1 2025 Net Product Revenues to $163.6 Thousand - Nasdaq

May 15, 2025
pulisher
May 15, 2025

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results - The Globe and Mail

May 15, 2025
pulisher
May 15, 2025

60 DEGREES PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 14, 2025

60 Degrees Pharmaceuticals (SXTP) to Release Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

KORE Group (KORE) to Release Quarterly Earnings on Thursday - Defense World

May 14, 2025
pulisher
May 14, 2025

SPAR Group (SGRP) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Society Pass (SOPA) Projected to Post Quarterly Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Windtree Therapeutics (WINT) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 14, 2025

Spero Therapeutics (SPRO) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 11, 2025

60 Degrees Pharmaceuticals’ (SXTP) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World

May 11, 2025

60 Degrees Pharmaceuticals Inc Azioni (SXTP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

60 Degrees Pharmaceuticals Inc Azioni (SXTP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
XU CHERYL
Director
Dec 12 '24
Buy
1.82
5,000
9,125
46,078
XU CHERYL
Director
Dec 16 '24
Buy
1.45
2,000
2,900
54,078
DOW GEOFFREY S
President and CEO
Dec 09 '24
Buy
1.27
35,823
45,563
94,580
DOW GEOFFREY S
President and CEO
Dec 06 '24
Buy
1.20
20,579
24,672
58,757
DOW GEOFFREY S
President and CEO
Dec 05 '24
Buy
1.11
17,549
19,520
38,178
DOW GEOFFREY S
President and CEO
Nov 21 '24
Buy
0.91
3,500
3,195
20,629
DOW GEOFFREY S
President and CEO
Nov 19 '24
Buy
0.90
2,500
2,248
16,129
DOW GEOFFREY S
President and CEO
Nov 20 '24
Buy
0.92
1,000
924
17,129
XU CHERYL
Director
Aug 27 '24
Buy
1.70
5,000
8,500
41,078
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Capitalizzazione:     |  Volume (24 ore):